Publications by authors named "K Gardey"

Background: Temporary transvenous pacing (TTP) is a common procedure, predominantly performed in the catheterization laboratory (cath lab) because of presumed lower complication rate. This study aims to evaluate the efficacy and safety of TTP placement in the ICU compared to TTP placement in the cath lab.

Methods: This retrospective, real-life study included all patients requiring TTP in a tertiary care ICU between 2019 and 2022.

View Article and Find Full Text PDF
Article Synopsis
  • A study was conducted to assess how well two wearable ECG devices, the Apple Watch and KardiaMobile 6L, can accurately measure important heart metrics in patients with congenital long QT syndrome (LQTS).* -
  • Researchers compared these wearable devices' readings to a standard 12-lead ECG in 98 patients and found that both devices offered moderate to strong correlations, especially in measuring the corrected QT interval and analyzing ST-T wave patterns.* -
  • While the wearable devices showed promise as additional monitoring tools, they are not a substitute for traditional 12-lead ECG tests in managing patients with LQTS.*
View Article and Find Full Text PDF

Aims: The incidence of atrial tachyarrhythmias is high in patients with atrioventricular septal defect (AVSD). No specific data on catheter ablation have been reported so far in this population. We aimed to describe the main mechanisms of atrial tachyarrhythmias in patients with AVSD and to analyse outcomes after catheter ablation.

View Article and Find Full Text PDF

Background: Ventricular arrhythmias and sudden death are recognized complications in tetralogy of Fallot. Electrophysiological studies (EPS) before pulmonary valve replacement (PVR), the most common reintervention in tetralogy of Fallot, could potentially inform therapy to improve arrhythmic outcomes.

Methods: A prospective multicenter study was conducted to systematically assess EPS with programmed ventricular stimulation in patients with tetralogy of Fallot referred for PVR from January 2020 to December 2021.

View Article and Find Full Text PDF

Arrhythmogenic cardiomyopathy (ACM) is a rare genetic disease associated with ventricular arrhythmias in patients. The occurrence of these arrhythmias is due to direct electrophysiological remodeling of the cardiomyocytes, namely a reduction in the action potential duration (APD) and a disturbance of Ca homeostasis. Interestingly, spironolactone (SP), a mineralocorticoid receptor antagonist, is known to block K channels and may reduce arrhythmias.

View Article and Find Full Text PDF